These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36851999)
1. Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease. Sun T; Wang C; Huo L; Wang Y; Liu K; Wei C; Zhao H; Chen S; Ren L Int J Gen Med; 2023; 16():631-639. PubMed ID: 36851999 [TBL] [Abstract][Full Text] [Related]
2. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease. Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647 [TBL] [Abstract][Full Text] [Related]
3. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus. Zhang Z; Wang J; Wang H Exp Ther Med; 2018 Mar; 15(3):2936-2940. PubMed ID: 29456698 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus]. Guo M; Xi G; Yang N; Yao H Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967 [TBL] [Abstract][Full Text] [Related]
5. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197 [No Abstract] [Full Text] [Related]
6. Circulating levels of cortistatin are correlated with metabolic parameters in patients with newly diagnosed type 2 diabetes mellitus. Chen W; Fu Y; Yin X; Liu Y Peptides; 2017 Aug; 94():86-90. PubMed ID: 28526556 [TBL] [Abstract][Full Text] [Related]
7. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662 [No Abstract] [Full Text] [Related]
8. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance. Li JY; Wu GM; Hou Z; Cao YM Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006 [TBL] [Abstract][Full Text] [Related]
9. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients. Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497 [TBL] [Abstract][Full Text] [Related]
10. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease. Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055 [TBL] [Abstract][Full Text] [Related]
11. The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD). Hu Y; Chen J; Yang L; Chen P; Li J; Chen L; Chen J; Huang X; Zhang Y; Bu S; Huang Q J Clin Transl Endocrinol; 2014 Dec; 1(4):133-139. PubMed ID: 29159094 [TBL] [Abstract][Full Text] [Related]
12. Correlation of CD3+/CD4+, and serum CK-18 fragment levels with glucose and lipid metabolism in elderly type 2 diabetes patients with nonalcoholic fatty liver disease. Zhao C; Lou F; Li X; Ma J; Zhu Z; Li H; Zhai Y; Chen H; Zhang Q; Liu Z; Xiao S Am J Transl Res; 2021; 13(4):2546-2554. PubMed ID: 34017413 [TBL] [Abstract][Full Text] [Related]
13. Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients. Zhou X; Luo M; Zhou S; Cheng Z; Chen Z; Yu X Diabetes Metab Syndr Obes; 2021; 14():379-385. PubMed ID: 33536771 [TBL] [Abstract][Full Text] [Related]
14. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs. Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638 [TBL] [Abstract][Full Text] [Related]
16. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone. Chai SY; Pan XY; Song KX; Huang YY; Li F; Cheng XY; Qu S Lipids Health Dis; 2014 Jan; 13():7. PubMed ID: 24397589 [TBL] [Abstract][Full Text] [Related]
18. [Correlation of retinol binding protein 4 with metabolic indexes of glucose and lipid, bile cholesterol saturation index]. Wang W; Li N Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 40(6):657-65. PubMed ID: 26164516 [TBL] [Abstract][Full Text] [Related]
19. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid. Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181 [TBL] [Abstract][Full Text] [Related]
20. Plasma miR-513a-5p as a Potential Biomarker for Diagnosis of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients. Li F; Wu X; Zhang Y; Wei K Clin Lab; 2020 May; 66(5):. PubMed ID: 32390388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]